homocysteine and gemfibrozil

homocysteine has been researched along with gemfibrozil in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, JK; Blumenthal, aR; Nass, CM; Post, WS; Wiviott, SD1
Dierkes, J; Luley, C; Westphal, S1
Bostom, AG1
Chan, NN; Chow, FC1
Frick, MH; Humphries, SE; Kesäniemi, YA; Nieminen, MS; Pasternack, A; Syvänne, M; Taskinen, MR; Turpeinen, U; Whittall, RA1
Contant, CF; Francone, OL; Gao, X; Lewin, AJ; Nguyen, TT; Terra, SG1

Trials

3 trial(s) available for homocysteine and gemfibrozil

ArticleYear
Effects of fenofibrate and gemfibrozil on plasma homocysteine.
    Lancet (London, England), 2001, Jul-07, Volume: 358, Issue:9275

    Topics: Adult; Aged; Creatinine; Cross-Over Studies; Cystatin C; Cystatins; Fenofibrate; Gemfibrozil; Homocysteine; Humans; Hypertriglyceridemia; Lipids; Male; Middle Aged

2001
Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis.
    Atherosclerosis, 2004, Volume: 172, Issue:2

    Topics: Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Gemfibrozil; Homocysteine; Humans; Hypolipidemic Agents; Male; Methylenetetrahydrofolate Reductase (NADPH2); Triglycerides

2004
Efficacy and safety of a potent and selective peroxisome proliferator activated receptor alpha agonist in subjects with dyslipidemia and type 2 diabetes mellitus.
    The American journal of cardiology, 2008, Aug-15, Volume: 102, Issue:4

    Topics: Adult; Aged; Apolipoprotein A-I; Apolipoprotein B-100; C-Reactive Protein; Cholesterol, HDL; Diabetes Mellitus, Type 2; Double-Blind Method; Dyslipidemias; Female; Fenofibrate; Gemfibrozil; Homocysteine; Humans; Hypolipidemic Agents; Male; Middle Aged; PPAR alpha

2008

Other Studies

3 other study(ies) available for homocysteine and gemfibrozil

ArticleYear
Global risk assessment for lipid therapy to prevent coronary heart disease.
    Current cardiology reports, 2000, Volume: 2, Issue:5

    Topics: Blood Flow Velocity; Carotid Arteries; Coronary Disease; Exercise Test; Gemfibrozil; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Risk Assessment; Risk Factors; Tunica Intima

2000
Effects of fenofibrate and gemfibrozil on plasma homocysteine.
    Lancet (London, England), 2001, Nov-24, Volume: 358, Issue:9295

    Topics: Creatinine; Fenofibrate; Gemfibrozil; Glomerular Filtration Rate; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Reproducibility of Results

2001
Effects of fenofibrate and gemfibrozil on plasma homocysteine.
    Lancet (London, England), 2001, Nov-24, Volume: 358, Issue:9295

    Topics: Fenofibrate; Fibrinogen; Gemfibrozil; Homocysteine; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Receptors, Cytoplasmic and Nuclear; Transcription Factors

2001